Corcept Therapeutics Incorporated financial statements, including revenue, expenses, profit, and loss
The total revenue of CORT for the last quarter is 135.41 M USD, and it's 9.55% higher compared to the previous quarter. The net income of Q4 23 is 31.14 M USD.